David Evans, Ph.D.

Go-getter
DISC Type : d

Head of Discovery at Sirnaomics

Germantown, Maryland, United States

Overview

David Evans is the Head of Discovery Research and co-founder of Sirnaomics, where he leads the development of siRNA therapeutics for oncology, fibrosis, and infectious diseases. An alumnus of Imperial College London, he is a seasoned R&D leader with extensive experience in driving multiple drug candidates from discovery to clinical-stage trials.

He is described as a creative leader who is rich in ideas for new technological solutions to problems in drug screening. People who have worked with him note that he fosters an innovative and enjoyable work environment.

Interesting fact: David is a serial entrepreneur, having co-founded several therapeutic, diagnostic, and instrumentation companies throughout his career.

Personality Overview

Direct & Candid

Vision Oriented

Challenger

They can be nudged to make faster decisions by offering what they value.  They don’t always try to control the conversation but neither do they like yielding it fully. They care equally about the product and its potential impact.

Topics They Care About

RNAi Therapeutics
He is a pioneer in the field, leading Sirnaomics' efforts in developing novel siRNA therapeutics and has been involved in RNAi since 2003.
Oncology Drug Discovery
His work is heavily focused on developing treatments for various cancers, including Non-Melanoma Skin Cancer, TNBC, and NSCLC, using novel delivery mechanisms.
Targeted Drug Delivery
He is actively developing advanced delivery systems like Polypeptide Nanoparticles (PNP) and Antibody Oligo Drug Conjugates (AODC) to enhance therapeutic efficacy.

Media Appearances

Sirnaomics Appoints Dr. David Evans as Chief Scientific Officer to Lead Preclinical Programs for Novel Antifibrosis and Anticancer RNAi Therapeutics. Featured in PR Newswire

See Now

Dr. David Mark Evans – Head: Drug Discovery & Collaboration, Sirnaomics Ltd. Featured in Bloomberg

See Now

Sirnaomics Use of PNI Microfluidics to Manufacture GMP Quality siRNA Nanoparticles – Dr. David Evans. Featured in YouTube

See Now

Work History

3-2023
Head of Discovery at Sirnaomics
6-2018 - 3-2023
Chief Scientific Officer at Sirnaomics
3-2013 - 6-2018
Manager In Vitro Screening groups at Frederick National Lab for Cancer Research (NCI)
1-2012 - 12-2012
VP Operations at Emerald BioStructures and BioSystems
6-2008
Scientific advisor at Consultant

Education

10-1983 - 6-1987
Ph.D from Imperial College London

More Information

Social Presence :

Prographics :

Exp : 31 Location : Germantown, Maryland, United States Job Level : Mid-senior Designation : Head of Discovery at Sirnaomics
URL has been copied!

Insights For Selling To David

During A Call Or A Meeting

DO's

  • Make sure that they have the necessary authority, they could present false stature sometimes
  • Highlight the competitive differentiation of your product
  • Ask them questions confidently while doing discovery, don’t be apologetic

DONT's

  • Don't try too hard to get friendly, let it happen with time
  • Do not give up if they are not convinced, try again with a different approach
  • Don’t expect them to change their mind quickly if they say no once

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with David is

  • Confidence in the product plays an important role, followed by powerful testimonials.
  • Will you ever get a clear answer from David

  • They might hesitate a little, but they will say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will David move?

  • They are neither the fastest decision makers nor the slowest.
  • Can David take some risk or not?

  • Once they have analyzed the pros and cons, they can take some risks.

You And David

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.